Data from: Screening test for neutralizing antibodies against yellow fever virus, based on a flavivirus pseudotype

Séverine Mercier-Delarue, Christine Durier, Nathalie Colin De Verdière, Jean-Dominique Poveda, VIncent Meiffrédy, Maria Dolores Fernandez Garcia, Stephane Lastère, Raymond Césaire, Jean-Claude Manuggera, Jean-Michel Molina, Ali Amara & François Simon
Given the possibility of yellow fever virus reintroduction in epidemiologically receptive geographic areas, the risk of vaccine supply disruption is a serious issue. New strategies to reduce the doses of injected vaccines should be evaluated very carefully in terms of immunogenicity. The plaque reduction test for the determination of neutralizing antibodies (PRNT) is particularly time-consuming and requires the use of a confinement laboratory. We have developed a new test based on the use of a...

Registration Year

  • 2017
    1

Resource Types

  • Dataset
    1

Affiliations

  • Saint Louis University Hospital
    1
  • Inserm
    1
  • Institut Pasteur
    1